Assay of myo-inositol in cerebrospinal fluid and plasma by chemical ionization mass spectrometry of the hexaacetate derivative.

The paper describes a capillary gas chromatographic/mass spectrometric technique to quantitate myo-inositol in cerebrospinal fluid (CSF) and plasma. A highly abundant fragment ion, m/z 373, for the hexaacetate derivative of myo-inositol was generated by chemical ionization (CI). This ion and the analogous ion of hexadeuterated myo-inositol (the internal standard), m/z 379, were both monitored in the assay. CI was performed with acetonitrile vapor in an ion trap mass spectrometer. Microliter quantities of CSF or plasma were mixed with the internal standard, dried and acetylated. After a post-derivatization clean-up, samples were analyzed on a capillary gas chromatograph interfaced with a Finnigan ion trap. Standard curves constructed for both CSF and plasma were linear and reproducible. Absence of matrix effects and good precision in the results indicate the suitability of the technique for critical assays. Results from the determination of myo-inositol in the CSF and plasma of healthy subjects and those with neurological deficits are reported.

[1]  B D Ross,et al.  Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy. , 1993, Radiology.

[2]  J. Growdon,et al.  Evidence for a membrane defect in Alzheimer disease brain. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[3]  N. Greig,et al.  An automatic reaction control chemical ionization technique in ion trap detector for quantitative plasma profding of arecoline in treated alzheimer patients , 1991, Journal of the American Society for Mass Spectrometry.

[4]  J. Haxby,et al.  Lumbar cerebrospinal fluid choline in healthy aging and in Down's syndrome. , 1990, Archives of neurology.

[5]  B. Fruen,et al.  Down's syndrome fibroblasts exhibit enhanced inositol uptake. , 1990, The Biochemical journal.

[6]  H. Chigasaki,et al.  Polyol content of cerebrospinal fluid in brain-tumor patients. , 1989, Journal of neurosurgery.

[7]  S. Rapoport,et al.  Quantitative analysis of polyols in human plasma and cerebrospinal fluid. , 1989, Journal of chromatography.

[8]  G. Glish,et al.  Self chemical ionization in an ion trap mass spectrometer , 1988 .

[9]  R. Foltz,et al.  Chemical ionization with the ion trap detector: Application to a drug assay requiring a wide dynamic range , 1988 .

[10]  G. Dijkstra,et al.  Structure and formation of gaseous [C3H4N]+ ions† , 1986 .

[11]  B. Wolf,et al.  Quantitation of myo-inositol as its hexakis(trifluoroacetyl) derivative with negative ion chemical ionization mass spectrometry. , 1986, Biomedical & environmental mass spectrometry.

[12]  B. Holub Metabolism and function of myo-inositol and inositol phospholipids. , 1986, Annual review of nutrition.

[13]  C. Swahn,et al.  Gas Chromatographic‐Mass Spectrometric Determination of myo‐Inositol in Human Cerebrospinal Fluid , 1985, Journal of neurochemistry.

[14]  A. Karmen,et al.  Elevation of certain polyols in the cerebrospinal fluid of patients with multiple sclerosis. , 1984, Journal of chromatography.

[15]  Michael J. Berridge,et al.  Inositol trisphosphate, a novel second messenger in cellular signal transduction , 1984, Nature.

[16]  J. Andersen,et al.  Gas chromatographic mass spectrometric determination of myo-inositol in humans utilizing a deuterated internal standard. , 1982, Biomedical mass spectrometry.

[17]  G. King,et al.  The analysis of hexitols in biological fluid by selected ion monitoring. , 1980, Biomedical mass spectrometry.

[18]  G. Höfle,et al.  4‐Dialkylaminopyridines as Highly Active Acylation Catalysts. [New synthetic method (25)] , 1978 .

[19]  R. Fieve,et al.  Reduced myo-inositol levels in cerebrospinal fluid from patients with affective disorder. , 1978, Biological psychiatry.

[20]  J. Palo,et al.  POLYOLS IN THE CEREBROSPINAL FLUID AND PLASMA OF NEUROLOGICAL, DIABETIC AND URAEMIC PATIENTS , 1977, Acta neurologica Scandinavica.

[21]  W. Sherman,et al.  Measurement of myo-inositol in single cells and defined areas of the nervous system by selected ion monitoring. , 1977, Analytical biochemistry.

[22]  L. Lewin,et al.  Elevated myo-inositol concentrations in cerebrospinal fluid of neonates and of patients with an impaired state of consciousness. , 1976, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

[23]  W. Sherman,et al.  Combined gas chromatography-mass spectrometry of the inositol trimethylsilyl ethers and acetate esters , 1970 .